Zacks Investment ResearchFri, 08 May 2026 00:11:50 GMT4D Molecular Therapeutics, Inc. (FDMT) Reports Q1 Loss, Lags Revenue EstimatesFDMT+2.11%
Zacks Investment ResearchWed, 18 Mar 2026 22:25:31 GMT4D Molecular Therapeutics, Inc. (FDMT) Q4 Earnings and Revenues Beat EstimatesFDMT+2.11%
Seeking AlphaFri, 06 Mar 2026 18:46:01 GMT4D Molecular Therapeutics, Inc. (FDMT) Presents at TD Cowen 46th Annual Health Care Conference Prepared Remarks TranscriptFDMT+2.11%